FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789774540> ?p ?o ?g. }

• W2789774540 endingPage "1582" @default.
• W2789774540 startingPage "1574" @default.
• W2789774540 abstract "Abstract Context MYC-associated factor X (MAX) has been recently described as a new susceptibility pheochromocytoma (PHEO) gene with a total of ~40 reported cases. At present, no study has specifically described the functional imaging phenotype of MAX-related PHEO. Objective, Patients, and Design The objective of the present study was to present our experience with contrast-enhanced computed tomography (CT) and 18F-fluorodihydroxyphenylalanine (18F-FDOPA) positron emission tomography (PET)/CT in six consecutive patients (four at the initial diagnosis and two at the follow-up evaluation) with rare, but clinically important, MAX-related PHEOs. In five patients, 18F-FDOPA was also compared with other radiopharmaceutical agents. Results The patients had five different mutations in the MAX gene that caused disruption of Max/Myc interaction and/or abolished interaction with DNA based on in silico analyses. All but one patient developed bilateral PHEOs during their lifetime. In all cases, 18F-FDOPA PET/CT accurately visualized PHEOs that were often multiple within the same gland or bilaterally and detected more adrenal and extra-adrenal lesions than did CT (per-lesion sensitivity, 90.9% vs 52.4% for CT/magnetic resonance imaging). The two PHEOs missed on 18F-FDOPA PET/CT were &lt;1 cm, corresponding to nodular adrenomedullary hyperplasia. 68Ga-DOTA,Tyr3-octreotate PET/CT detected fewer lesions than did 18F-FDOPA PET/CT in one of three patients, and 18F-fluorodeoxyglucose PET/CT was only faintly positive in two of four patients with underestimation of extra-adrenal lesions in one patient. Conclusions MAX-related PHEOs exhibit a marked 18F-FDOPA uptake, a finding that illustrates the common well-differentiated chromaffin pattern of PHEOs associated with activation of kinase signaling pathways. 18F-FDOPA PET/CT should be considered as the first-line functional imaging modality for diagnostic or follow-up evaluations for these patients." @default.
• W2789774540 created "2018-03-29" @default.
• W2789774540 creator A5006673441 @default.
• W2789774540 creator A5010409217 @default.
• W2789774540 creator A5012741329 @default.
• W2789774540 creator A5013015930 @default.
• W2789774540 creator A5013942288 @default.
• W2789774540 creator A5021627028 @default.
• W2789774540 creator A5034629462 @default.
• W2789774540 creator A5054150256 @default.
• W2789774540 creator A5068457694 @default.
• W2789774540 creator A5071255649 @default.
• W2789774540 creator A5072691128 @default.
• W2789774540 creator A5082738282 @default.
• W2789774540 creator A5089306310 @default.
• W2789774540 creator A5091023441 @default.
• W2789774540 date "2018-03-08" @default.
• W2789774540 modified "2023-10-17" @default.
• W2789774540 title "18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma" @default.
• W2789774540 cites W1966955143 @default.
• W2789774540 cites W1972618930 @default.
• W2789774540 cites W1978501585 @default.
• W2789774540 cites W2037381500 @default.
• W2789774540 cites W2046661986 @default.
• W2789774540 cites W2061662711 @default.
• W2789774540 cites W2069033623 @default.
• W2789774540 cites W2096249462 @default.
• W2789774540 cites W2104538433 @default.
• W2789774540 cites W2129128401 @default.
• W2789774540 cites W2130552225 @default.
• W2789774540 cites W2167435277 @default.
• W2789774540 cites W2194013758 @default.
• W2789774540 cites W2217618193 @default.
• W2789774540 cites W2304322755 @default.
• W2789774540 cites W2500385261 @default.
• W2789774540 cites W2550016662 @default.
• W2789774540 cites W2559026422 @default.
• W2789774540 cites W2585589460 @default.
• W2789774540 cites W2602310760 @default.
• W2789774540 cites W2604298996 @default.
• W2789774540 cites W2736142569 @default.
• W2789774540 cites W2743282746 @default.
• W2789774540 doi "https://doi.org/10.1210/jc.2017-02324" @default.
• W2789774540 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6276705" @default.
• W2789774540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29534198" @default.
• W2789774540 hasPublicationYear "2018" @default.
• W2789774540 type Work @default.
• W2789774540 sameAs 2789774540 @default.
• W2789774540 citedByCount "24" @default.
• W2789774540 countsByYear W27897745402018 @default.
• W2789774540 countsByYear W27897745402019 @default.
• W2789774540 countsByYear W27897745402020 @default.
• W2789774540 countsByYear W27897745402021 @default.
• W2789774540 countsByYear W27897745402022 @default.
• W2789774540 countsByYear W27897745402023 @default.
• W2789774540 crossrefType "journal-article" @default.
• W2789774540 hasAuthorship W2789774540A5006673441 @default.
• W2789774540 hasAuthorship W2789774540A5010409217 @default.
• W2789774540 hasAuthorship W2789774540A5012741329 @default.
• W2789774540 hasAuthorship W2789774540A5013015930 @default.
• W2789774540 hasAuthorship W2789774540A5013942288 @default.
• W2789774540 hasAuthorship W2789774540A5021627028 @default.
• W2789774540 hasAuthorship W2789774540A5034629462 @default.
• W2789774540 hasAuthorship W2789774540A5054150256 @default.
• W2789774540 hasAuthorship W2789774540A5068457694 @default.
• W2789774540 hasAuthorship W2789774540A5071255649 @default.
• W2789774540 hasAuthorship W2789774540A5072691128 @default.
• W2789774540 hasAuthorship W2789774540A5082738282 @default.
• W2789774540 hasAuthorship W2789774540A5089306310 @default.
• W2789774540 hasAuthorship W2789774540A5091023441 @default.
• W2789774540 hasBestOaLocation W27897745401 @default.
• W2789774540 hasConcept C126838900 @default.
• W2789774540 hasConcept C142724271 @default.
• W2789774540 hasConcept C143409427 @default.
• W2789774540 hasConcept C151730666 @default.
• W2789774540 hasConcept C2775842073 @default.
• W2789774540 hasConcept C2779343474 @default.
• W2789774540 hasConcept C2779512018 @default.
• W2789774540 hasConcept C2781156865 @default.
• W2789774540 hasConcept C2989005 @default.
• W2789774540 hasConcept C71924100 @default.
• W2789774540 hasConcept C86803240 @default.
• W2789774540 hasConceptScore W2789774540C126838900 @default.
• W2789774540 hasConceptScore W2789774540C142724271 @default.
• W2789774540 hasConceptScore W2789774540C143409427 @default.
• W2789774540 hasConceptScore W2789774540C151730666 @default.
• W2789774540 hasConceptScore W2789774540C2775842073 @default.
• W2789774540 hasConceptScore W2789774540C2779343474 @default.
• W2789774540 hasConceptScore W2789774540C2779512018 @default.
• W2789774540 hasConceptScore W2789774540C2781156865 @default.
• W2789774540 hasConceptScore W2789774540C2989005 @default.
• W2789774540 hasConceptScore W2789774540C71924100 @default.
• W2789774540 hasConceptScore W2789774540C86803240 @default.
• W2789774540 hasIssue "4" @default.
• W2789774540 hasLocation W27897745401 @default.
• W2789774540 hasLocation W27897745402 @default.
• W2789774540 hasLocation W27897745403 @default.
• W2789774540 hasLocation W27897745404 @default.

• next